Tel Mond, Israel

Sagy Tal

This inventor holds 2 USPTO granted patents. Top assignee: Alpha Tau Medical Ltd.. Active years: 2024-2025.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sagy Tal: Innovator in Radiotherapy Technology

Introduction

Sagy Tal is a prominent inventor based in Tel Mond, Israel. He has made significant contributions to the field of radiotherapy, particularly in the development of innovative template assemblies for brachytherapy. With a total of 2 patents, Tal's work is paving the way for advancements in cancer treatment.

Latest Patents

Sagy Tal's latest patents include a method of inserting brachytherapy seeds into a body organ. This method involves grasping the organ between a frame that defines a large central hole and an additional element. A grid, which defines a plurality of apertures, is placed on one side of the organ. A series of applicators are then passed through the apertures in both grids and through the organ itself. The brachytherapy seeds are anchored in the organ using the frame. His second patent is a template assembly that includes a first grid for placement on one side of the organ, defining multiple apertures for elongate applicators. A second grid is placed on the opposite side, also defining apertures for applicators that pass through both grids and the organ, with a frame positioned between them to securely grasp the organ.

Career Highlights

Sagy Tal is currently associated with Alpha Tau Medical Ltd., a company focused on innovative cancer treatment solutions. His work at Alpha Tau Medical has been instrumental in advancing the technology used in radiotherapy.

Collaborations

Sagy collaborates with talented individuals such as Ofer Magen and Niv Dana, contributing to a dynamic team dedicated to improving cancer treatment methodologies.

Conclusion

Sagy Tal's innovative contributions to radiotherapy technology highlight his commitment to enhancing cancer treatment options. His patents reflect a deep understanding of medical needs and technological solutions, making him a valuable figure in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…